159 related articles for article (PubMed ID: 23769811)
1. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.
Luhn P; Houldsworth J; Cahill L; Schiffman M; Castle PE; Zuna RE; Dunn ST; Gold MA; Walker J; Wentzensen N
Gynecol Oncol; 2013 Sep; 130(3):595-600. PubMed ID: 23769811
[TBL] [Abstract][Full Text] [Related]
2. Analysis of genetic copy number changes in cervical disease progression.
Policht FA; Song M; Sitailo S; O'Hare A; Ashfaq R; Muller CY; Morrison LE; King W; Sokolova IA
BMC Cancer; 2010 Aug; 10():432. PubMed ID: 20712890
[TBL] [Abstract][Full Text] [Related]
3. Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
Kudela E; Visnovsky J; Balharek T; Farkasova A; Zubor P; Plank L; Danko J
Ann Diagn Pathol; 2018 Aug; 35():16-20. PubMed ID: 30072014
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
5. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
6. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
Seppo A; Jalali GR; Babkowski R; Symiakaki H; Rodolakis A; Tafas T; Tsipouras P; Kilpatrick MW
Gynecol Oncol; 2009 Jul; 114(1):80-3. PubMed ID: 19394683
[TBL] [Abstract][Full Text] [Related]
7. Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.
Rodolakis A; Biliatis I; Symiakaki H; Kershnar E; Kilpatrick MW; Haidopoulos D; Thomakos N; Antsaklis A
Int J Gynecol Cancer; 2012 Jun; 22(5):742-7. PubMed ID: 22635026
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
9. Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living With HIV.
Mutetwa T; Liu Y; Silvera R; Evans M; Yurich M; Tripodi J; Leonard I; Houldsworth J; Gümüş Z; Bowcock AM; Sigel K; Gaisa M; Polak P
J Acquir Immune Defic Syndr; 2024 Jun; 96(2):190-195. PubMed ID: 38630441
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.
Mian C; Bancher D; Kohlberger P; Kainz C; Haitel A; Czerwenka K; Stani J; Breitenecker G; Wiener H
Gynecol Oncol; 1999 Oct; 75(1):41-6. PubMed ID: 10502423
[TBL] [Abstract][Full Text] [Related]
11. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
12. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
[TBL] [Abstract][Full Text] [Related]
13. Amplification of 3q26 and 5p15 regions in cervical intraepithelial neoplasia.
Kudela E; Farkasova A; Visnovsky J; Balharek T; Sumichrastova P; Sivakova J; Plank L; Danko J
Acta Obstet Gynecol Scand; 2014 Oct; 93(10):997-1002. PubMed ID: 25174982
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
[TBL] [Abstract][Full Text] [Related]
15. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
16. Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
Koeneman MM; Ovestad IT; Janssen EAM; Ummelen M; Kruitwagen RFPM; Hopman AH; Kruse AJ
Pathol Oncol Res; 2019 Apr; 25(2):549-557. PubMed ID: 30361910
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
18. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
19. FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.
Houldsworth J
Expert Rev Mol Diagn; 2014 Nov; 14(8):921-34. PubMed ID: 25308338
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
